Patient | Eye | DM | OCT | PreL CRT | PostL CRT (12 week) | Last PostL CRT | Decrease in CRT | Power (mW) | Spots | Follow up (months) | Changes on AF | PreL VA | PostL VA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | RE | II | IRC | 288 | 257 | 250 | 38 | 450 | 350 | 18 | NO | 20/22 | 20/22 |
1 | LE | II | IRC | 280 | 265 | 263 | 17 | 450 | 460 | 10 | NO | 20/22 | 20/22 |
2 | LE | I | IRC | 296 | 284 | 277 | 19 | 325 | 80 | 15 | NO | 20/22 | 20/20 |
3 | RE | I | IRC, NSD | 302 | 283 | 276 | 26 | 350 | 150 | 9 | NO | 20/20 | 20/20 |
4 | RE | II | IRC | 303 | 268 | 247 | 56 | 350 | 200 | 10 | NO | 20/22 | 20/22 |
5 | RE | I | IRC, IRE | 301 | 288 | 295 | 6 | 400 | 60 | 12 | NO | 20/25 | 20/22 |
5 | LE | I | IRC | 287 | 272 | 251 | 36 | 300 | 180 | 9 | NO | 20/32 | 20/32 |
6 | RE | II | IRC | 269 | 274 | 254 | 15 | 350 | 200 | 14 | NO | 20/28 | 20/28 |
7 | LE | II | IRC, IRE | 275 | 267 | 270 | 5 | 500 | 180 | 15 | YES | 20/28 | 20/25 |
8 | RE | II | IRC | 258 | 226 | 240 | 18 | 400 | 200 | 15 | NO | 20/28 | 20/25 |
8 | LE | II | IRC, IRE | 243 | 230 | 230 | 13 | 500 | 180 | 17 | YES | 20/32 | 20/25 |
9 | LE | II | IRC, IRE | 270 | 260 | 260 | 10 | 450 | 250 | 13 | NO | 20/32 | 20/25 |
10 | RE | I | IRC | 376 | 350 | 323 | 53 | 300 | 480 | 9 | NO | 20/20 | 20/20 |
10 | LE | I | IRC, NSD | 510 | 431 | 442 | 68 | 300 | 560 | 9 | NO | 20/20 | 20/20 |
11 | RE | II | IRC, IRE | 355 | 393 | 393 | −38 | 400 | 380 | 6 | NO | 20/32 | 20/25 |
12 | RE | II | IRC | 335 | 333 | 332 | 3 | 382 | 350 | 9 | NO | 20/28 | 20/28 |
13 | LE | II | IRC, IRE | 254 | 226 | 226 | 28 | 325 | 300 | 7 | NO | 20/22 | 20/22 |
14 | RE | II | IRC, IRE | 324 | 320 | 322 | 2 | 300 | 400 | 7 | NO | 20/22 | 20/22 |
15 | LE | II | IRC | 341 | 295 | 293 | 48 | 425 | 160 | 12 | NO | 20/32 | 20/25 |
16 | LE | II | NSD | 288 | 256 | 234 | 54 | 450 | 450 | 12 | NO | 20/25 | 20/20 |
17 | LE | II | IRC, IRE | 282 | 266 | 252 | 30 | 350 | 400 | 9 | NO | 20/20 | 20/20 |
18 | RE | II | IRC, IRE | 259 | 250 | 242 | 17 | 350 | 300 | 9 | NO | 20/20 | 20/20 |
19 | LE | II | IRE | 226 | 226 | 226 | 0 | 700 | 350 | 9 | NO | 20/28 | 20/28 |